| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974828 | The Journal of Heart and Lung Transplantation | 2005 | 5 Pages |
Abstract
Basiliximab induction therapy allows delayed initiation of cyclosporine after cardiac transplantation without an increase in rejection and reduces the risk of post-operative renal dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul B. MD, Ank E. MD, Mark H. MD, MSc, Daniel L. MD, MPH, Patricia A. RN, Linda S. PhD, J. Michael MD, Daniel MD, W. Steves MD, Clyde W. MD,